Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Dr R Kunz
Correspondence to: Dr R Kunz, University Hospital Basel, Switzerland; firstname.lastname@example.org
In patients with renal disease, do angiotensin receptor blockers (ARBs) reduce proteinuria more than placebo, other antihypertensive drugs, and their combinations?
Studies selected compared ARBs with placebo, ACE inhibitors, or other antihypertensive drugs in patients with renal disease and microalbuminuria or proteinuria. Randomised controlled trials (RCTs) that compared a combination of ARBs and ACE inhibitors with either drug alone were also included. Dose comparison studies or those in patients having renal transplant or with normal urinary protein excretion were excluded. Outcomes included albuminuria or proteinuria (albumin-creatinine or protein-creatinine ratios), and adverse effects.
Medline (1990–September 2006), Cochrane Central Register of Controlled Trials (2006, Issue 3), and reference lists of relevant articles were searched for English …
Source of funding: Santésuisse; the Gottfried and Julia Bangerter-Rhyner Foundation; Novartis.